手術部位感染対策市場レポート：製品、感染タイプ、手術タイプ、エンドユーザー、地域別、2024年～2032年

世界の手術部位感染対策市場規模は2023年に46億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに65億米ドルに達し、2024年から2032年の間に3.78%の成長率（CAGR）を示すと予測しています。外科手術の増加、医療関連感染に対する意識の高まり、患者の安全性への関心の高まり、医療費の急増などが、手術部位感染対策市場の成長を促進する主な要因となっています。

手術部位感染対策市場分析：

主な市場促進要因高齢化、座りがちなライフスタイル、不健康な食習慣などによる院内感染の増加や、がん、消化器疾患、心血管疾患（CVDs）などの慢性疾患の有病率の増加が、手術部位感染制御の採用を後押ししています。さらに、各国の政府機関や非政府機関が、厳格なガイドラインの導入や感染制御の実践に焦点を当てた研修プログラムの実施など、いくつかの積極的な取り組みを実施していることも、手術部位感染対策市場を後押ししています。

主な市場動向：手術部位感染のイントロダクションの増加、感染制御製品の技術的進歩の継続、低侵襲手術の採用の増加、厳格な規制基準の導入などが、手術部位感染対策市場の需要を促進すると予想されます。さらに、世界のヘルスケア支出の増加に伴い、患者の転帰を改善し、SSIを含む医療関連感染を減らすことに注目が集まっています。この動向は、手術環境における高度な感染制御ソリューションの需要を促進すると予想されます。

競合情勢：手術部位感染対策市場の主要企業としては、3M Company、Ansell Limited、Becton Dickinson and Company、bioMerieux SA.（Institut Merieux）、Covalon Technologies Ltd.、GAMA Healthcare Ltd.、Getinge AB（Carl Bennet AB）、Johnson &Johnson、Kimberly-Clark Corporation、Molnlycke Health Care AB、Prescient Surgical、Steris Corporationなどです。

地理的動向：報告書によると、北米は現在市場全体を支配しています。同地域は、手術部位感染対策製品およびサービスの世界最大級の市場です。市場規模は、手術件数の増加、高度なヘルスケアインフラ、幅広い規制状況、進行中の技術革新などの要因に影響されています。ヘルスケア関連感染に対する意識の高まりと感染予防対策の重要性により、市場は安定した成長を遂げています。

課題と機会：抗生物質耐性、コンプライアンス上の問題、コストへの配慮、医療施設による手術方法やプロトコルの違いなどは、市場が直面している課題の一部です。しかし、抗菌性コーティングの開発、新しい手術材料、ロボット支援手術などの医療技術の進歩は、手術環境における感染管理を強化する最近の動向を手術部位感染対策市場に提供しています。

手術部位感染対策市場傾向：

老年人口の増加

世界の多くの地域で、65歳以上の高齢者の割合の増加を特徴とする人口動態の変化が起きています。例えば、世界保健機関（WHO）によると、2030年までに世界の6人に1人が60歳以上となります。この時、60歳以上の人口比率は2020年の10億人から14億人に増加します。2050年には、世界の60歳以上の人口は2倍（21億人）になります。80歳以上の人口は2020年から2050年の間に3倍になり、4億2,600万人に達すると予想されています。高齢者は、加齢に伴う免疫系の変化、組織治癒能力の低下、糖尿病、高血圧、心血管疾患などの併存疾患の存在により、SSIに対してより脆弱です。老年人口の増加に伴い、高齢者に行われる外科手術の数も増加し、SSIのリスクを軽減するための感染管理対策への需要が高まっています。例えば、国立医学図書館が2021年3月に発表した論文によると、65歳以上の高齢者に対して毎年400万件近くの外科手術が行われています。これと同様に、2023年3月に国立医学図書館が発表した別の論文によると、人工膝関節全置換術では、61～65歳の年齢層と比較して、76～80歳の高齢者ではSSI発生率が高かったです。これらの要因は、手術部位感染市場の収益をさらに押し上げています。

手術手技の増加とヘルスケアインフラの発展

世界中で外科手術が大幅に増加しています。例えば、国立医学図書館が発表した論文によると、2020年9月には、世界の疾病負担の11％が外科的介入、麻酔管理、またはその両方を必要としています。最も多い手術は、白内障（22.8％）、帝王切開（3.8％）、骨折手術（3.27％）、ヘルニア（2.86％）です。必要な手術は全手術の44.2％を占めました。さらに、特に新興国市場におけるヘルスケア・インフラ開拓の取り組みが、手術部位感染対策市場の成長に寄与しています。India Investment Gridが発表した記事によると、公的医療支出は2025年までにGDPの2.5％まで上昇すると予想されています。これとは別に、ヘルスケア施設やプロバイダーは、SSIの発生を最小限に抑えるための予防戦略や技術への投資を増やしています。これには、厳格なプロトコルの採用、高度な滅菌技術、手術器具の抗菌コーティング、創傷被覆材や縫合糸におけるハイテク素材の利用などが含まれます。例えば、2023年12月、フリンダース大学と中国の研究者が共同で、感染に強い新しいAg-Ga整形外科用インプラントの被覆材を開発しました。この新素材は、多数の医療器具にスプレーキャストすることで、感染から保護すると同時に、抗炎症作用も発揮するため、容易かつ制御可能です。さらに、2023年10月、Sylke Inc.は、純粋な低アレルギー性絹フィブロインから製造されたドレッシング材SYLKEを発表しました。SYLKEは手術創の治癒を促進し、瘢痕形成不全の原因となる合併症や感染症を軽減します。SYLKEは、感染症や劣悪な瘢痕形成の原因となる医療用接着剤に関連した皮膚損傷を取り除くことで、手術創ケアの変革を目指します。

調査研究と臨床試験の進歩

研究開発と臨床試験の進歩は、革新的な製品の開発を促進し、治療戦略を強化し、患者の転帰を改善することで、手術部位感染対策市場の成長を牽引する重要な役割を果たしています。例えば、2024年2月、外科手術の予後を改善するバイオ医薬品企業であるPolyPid Ltd.は、SHIELD II第3相臨床試験で100人目の患者を登録し、大きな進展があったことを発表しました。この調査は、腹部大腸手術における手術部位感染（SSI）予防を目的とした製品候補であるD-PLEX100の有効性を調べたものです。SHIELD II試験のトップライン結果は2024年後半に期待され、約40ヵ所がこの試験に積極的に参加しています。さらに、調査研究および臨床試験は、手術環境における感染予防および制御のためのベストプラクティスおよびガイドラインの特定に貢献しています。術前準備、手術手技、抗菌薬予防、術後ケアに関するエビデンスに基づく推奨は、プロトコルの標準化と感染対策の遵守向上に役立ち、最終的にはSSIの発生率を低下させ、患者の転帰を改善します。例えば、2023年8月にエモリー大学が実施した調査では、20,000人以上の患者を対象に、自動化された方法でフィードバックを提供し、パフォーマンスを評価したところ、抗生物質予防投与の遵守率が12％増加し、SSI全体が33％減少しました。Surgical Infection Society（外科感染学会）の2023年年次総会で発表されたデータでは、独自の自動化された抗生物質予防投与アプローチが手術部位感染を大幅に減少させることが示されました。これらの要因は、手術部位感染対策市場予測にさらにプラスの影響を与えています。

手術部位感染対策の主要市場セグメンテーション：

IMARC Groupは、世界の手術部位感染対策市場レポートの各サブセグメントにおける主要動向の分析と、2024年から2032年までの世界、地域、国別レベルでの予測を提供しています。当レポートでは、製品タイプ、感染タイプ、手術タイプ、エンドユーザー別に市場を分類しています。

製品別の内訳

抗生物質予防製品

創傷ケアドレッシング

手術用ドレープ

手術用バリカン

防腐剤および消毒剤

創傷灌流製品

その他

抗生物質予防製品は現在市場で明確な優位性を示す

本レポートでは、製品別に市場を詳細に区分・分析しています。これには、抗生物質予防製品、創傷ケアドレッシング、手術用ドレープ、手術用バリカン、防腐剤・消毒剤、創傷灌漑製品、その他が含まれます。報告書によると、抗生物質予防製品が世界市場シェアの大半を占めています。

手術部位感染対策市場の展望によると、抗生物質の予防投与は、ヘルスケア環境において重大な懸念事項である手術部位感染（SSI）の予防において重要な役割を果たしています。抗生物質は通常、細菌汚染の可能性がある時点で適切な組織濃度になるように、手術切開の直前に投与されます。投与のタイミングは非常に重要であり、理想的には外科的切開の60分前以内に行うべきであるが、抗生物質や処置によっては例外もあります。さらに、予防的抗菌薬レジメンは、さまざまな外科手術の特殊な要件に合わせて調整されることが多いです。例えば、整形外科手術では黄色ブドウ球菌や連鎖球菌に対するカバーが必要な場合があり、一方、大腸肛門外科手術ではグラム陰性菌や嫌気性菌に対する追加カバーが必要な場合があります。例えば、2024年1月、米国外傷外科学会（AAST）、世界外科感染学会欧州（SIS-E）、外科感染世界アライアンス（GAIS）、世界救急外科学会（WSES）は共同で、頭部、脳、胴体、顎顔面領域、四肢、皮膚、軟部組織を含む外傷性病変の症例における抗生物質予防（AP）に関する重要なガイドラインを作成しました。

感染タイプ別内訳

表在性切開創SSI

深部切開創SSI

臓器・腔内SSI

現在、表在性切開創SSIが世界市場シェアの大半を占める

本レポートでは、感染タイプに基づく市場の詳細な区分と分析も行っています。これには、表在性切開SSI、深在性切開SSI、臓器・腔内SSIが含まれます。同レポートによると、表在性切開SSIが現在最大の市場シェアを占めています。

手術部位感染市場概要によると、表在性切開創手術部位感染（SSI）は全SSIの大部分を占める。これらの感染症は術後30日以内に発生し、切開部の皮膚と皮下組織のみを侵します。多くの場合、手術部位の発赤、熱感、腫脹、局所的な疼痛などの症状が特徴的です。SSIは、外科診療で遭遇する最も一般的なタイプのSSIのひとつです。発生率が比較的高いことから、感染制御の取り組みにおける重要性が強調されます。例えば、米国国立医学図書館が2023年に発表した論文によると、SSI患者全体の59％が表在性SSIでした。

手術の種類別内訳

帝王切開

胃バイパス術

白内障手術

歯科修復

その他

帝王切開術が現在最大の市場シェアを占める

本レポートでは、手術タイプに基づく市場の詳細な区分と分析を行っています。これには、帝王切開、胃バイパス、白内障手術、歯科修復、その他が含まれます。報告書によると、帝王切開は市場全体で最大のシェアを占めています。

帝王切開は世界的に最も一般的な外科手術の一つです。多くの国で、帝王切開分娩の割合は年々着実に増加しています。このように大量の手術が行われるため、帝王切開におけるSSIの予防は、感染管理対策の重要な焦点となっています。さらに、帝王切開の手術部位は、多数の細菌が生息する生殖器や消化管に近いため、特に感染しやすいです。さらに、この手技では皮膚と子宮壁の保護バリアが破られるため、汚染のリスクが高まる。これとは別に、帝王切開後のSSIは、母親と新生児の両方に深刻な結果をもたらす可能性があります。SSIは母体に不快感を与え、入院を長引かせるだけでなく、子宮内膜炎、創部剥離、敗血症などの合併症を引き起こし、ヘルスケアコストの増加につながります。また、病原体が新生児に垂直感染し、新生児感染症を引き起こすリスクもあります。例えば、世界保健機関（WHO）のデータによると、帝王切開の利用は増加しており、2021年には5人に1人（21％）を超えます。この数字は今後10年間でさらに上昇し、2030年には全出産のほぼ3分の1（29％）が帝王切開によるものとなると予想されています。

エンドユーザー別内訳

病院

外来手術センター

その他

現在、病院が市場で明確な優位性を示しています。

本レポートでは、エンドユーザーに基づく市場の詳細な区分と分析も提供しています。これには病院、外来手術センター、その他が含まれます。手術部位感染対策市場レポートによると、病院が市場で明確な優位性を示しています。

病院における手術部位感染（SSI）対策の需要は、患者の安全性、ヘルスケアの質、規制要件、財政的配慮に関連するさまざまな要因から生じています。SSIの予防は、患者の安全を確保し、術後合併症のリスクを最小限に抑えるために不可欠です。SSIは重大な罹患率、入院期間の延長、医療費の増加、そして重症の場合は死亡につながる可能性があります。病院には、患者に安全で質の高い医療を提供する道徳的・倫理的な義務があり、これにはSSIを抑制する対策の実施も含まれます。さらに、病院は質の高いケアを提供し、地域社会で良い評判を維持することにますます重点を置くようになっています。SSIの予防は、ヘルスケアの質向上の取り組みの基本です。SSIを効果的にコントロールしている病院は、患者、医療従事者、保険会社、規制当局から、より安全で信頼できる病院として認識されています。

地域別内訳

北米

米国

カナダ

アジア太平洋

中国

日本

インド

韓国

オーストラリア

インドネシア

その他

欧州

ドイツ

フランス

英国

イタリア

スペイン

ロシア

その他

ラテンアメリカ

ブラジル

メキシコ

その他

中東・アフリカ

現在、北米が世界市場を独占

この調査レポートは、北米（米国、カナダ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、インドネシア、その他）、ラテンアメリカ（ブラジル、メキシコ、その他）、中東アフリカを含むすべての主要地域市場の包括的な分析も提供しています。同レポートによると、現在世界市場を独占しているのは北米です。

手術部位感染対策市場統計によると、北米はヘルスケア製品とサービスの世界最大市場の一つです。その中で、SSI対策市場には、抗菌剤、手術用ドレープ、手袋、滅菌機器、創傷ケア製品、監視システムなど、幅広い製品が含まれています。手術手技や感染対策の進歩にもかかわらず、SSIは北米のヘルスケア施設では依然として大きな懸念事項です。SSIの有病率は外科の専門分野や環境によって異なりますが、ヘルスケアシステムにとって臨床的にも経済的にも大きな負担となっています。例えば、2021年2月、ペンシルベニア医学部は新しいインターベンショナル・サポート・センター（ISC）を開設し、米国フィラデルフィア南西部で最も著名な器具処理および手術用品準備施設のひとつとなった。ISCは、この種の施設としてはペンシルベニア州初の施設のひとつで、スタッフは手術や処置の準備のために、基本的なハサミやクランプから複雑なロボット器具に至るまで、毎日何千もの器具を滅菌・包装しています。例えば、国立医学図書館が発表した論文によると、2024年2月、米国では手術部位感染が約200万件の院内感染を占め、術後の罹患率や死亡率をかなり高めています。これに伴い、マクマスター大学とメリーランド大学医学部が2024年2月に共同で実施した国際試験によると、閉鎖骨折の手術を受ける毎年数千人の患者が、アルコールにヨウ素を溶かしたポバクリレックスを使用して皮膚を消毒することで、手術部位感染を回避できる可能性があります。

本レポートで扱う主な質問

• 世界の手術部位感染対策市場の市場規模は？
• 2024-2032年における世界の手術部位感染対策市場の予想成長率は？
• 世界の手術部位感染対策市場を牽引する主要因は？
• 世界の手術部位感染対策市場に対するCOVID-19の影響は？
• 世界の手術部位感染対策市場の製品別内訳は？
• 世界の手術部位感染対策市場の感染タイプ別内訳は？
• 世界の手術部位感染対策市場のエンドユーザー別内訳は？
• 世界の手術部位感染対策市場の主要地域は？
• 世界の手術部位感染対策市場の主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の手術部位感染対策市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品別

• 抗生物質予防製品
  • 市場動向
  • 市場予測
• 創傷ケア用ドレッシング
  • 市場動向
  • 市場予測
• 手術用ドレープ
  • 市場動向
  • 市場予測
• 外科用バリカン
  • 市場動向
  • 市場予測
• 消毒剤と殺菌剤
  • 市場動向
  • 市場予測
• 創傷洗浄製品
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第7章 市場内訳：感染タイプ別

• 浅切開SSI
  • 市場動向
  • 市場予測
• 深切開SSI
  • 市場動向
  • 市場予測
• 臓器または空間SSI
  • 市場動向
  • 市場予測

第8章 市場内訳：手術タイプ別

• 帝王切開
  • 市場動向
  • 市場予測
• 胃バイパス
  • 市場動向
  • 市場予測
• 白内障手術
  • 市場動向
  • 市場予測
• 歯科修復
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第9章 市場内訳：エンドユーザー別

• 病院
  • 市場動向
  • 市場予測
• 外来手術センター
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第10章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第11章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第14章 価格分析

第15章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • 3M Company
  • Ansell Limited
  • Becton Dickinson and Company
  • bioMerieux SA.（Institut Merieux）
  • Covalon Technologies Ltd.
  • GAMA Healthcare Ltd.
  • Getinge AB（Carl Bennet AB）
  • Johnson & Johnson
  • Kimberly-Clark Corporation
  • Molnlycke Health Care AB
  • Prescient Surgical
  • Steris Corporation

List of Figures

• Figure 1: Global: Surgical Site Infection Control Market: Major Drivers and Challenges
• Figure 2: Global: Surgical Site Infection Control Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Surgical Site Infection Control Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Surgical Site Infection Control Market: Breakup by Product (in %), 2023
• Figure 5: Global: Surgical Site Infection Control Market: Breakup by Infection Type (in %), 2023
• Figure 6: Global: Surgical Site Infection Control Market: Breakup by Surgery Type (in %), 2023
• Figure 7: Global: Surgical Site Infection Control Market: Breakup by End User (in %), 2023
• Figure 8: Global: Surgical Site Infection Control Market: Breakup by Region (in %), 2023
• Figure 9: Global: Surgical Site Infection Control (Antibiotic Prophylaxis Products) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 10: Global: Surgical Site Infection Control (Antibiotic Prophylaxis Products) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 11: Global: Surgical Site Infection Control (Wound Care Dressings) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 12: Global: Surgical Site Infection Control (Wound Care Dressings) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 13: Global: Surgical Site Infection Control (Surgical Drapes) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 14: Global: Surgical Site Infection Control (Surgical Drapes) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 15: Global: Surgical Site Infection Control (Surgical Clippers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 16: Global: Surgical Site Infection Control (Surgical Clippers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 17: Global: Surgical Site Infection Control (Antiseptics and Disinfectants) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 18: Global: Surgical Site Infection Control (Antiseptics and Disinfectants) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 19: Global: Surgical Site Infection Control (Wound Irrigation Products) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 20: Global: Surgical Site Infection Control (Wound Irrigation Products) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 21: Global: Surgical Site Infection Control (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 22: Global: Surgical Site Infection Control (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 23: Global: Surgical Site Infection Control (Superficial Incisional SSI) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 24: Global: Surgical Site Infection Control (Superficial Incisional SSI) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 25: Global: Surgical Site Infection Control (Deep Incisional SSI) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 26: Global: Surgical Site Infection Control (Deep Incisional SSI) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 27: Global: Surgical Site Infection Control (Organ or Space SSI) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 28: Global: Surgical Site Infection Control (Organ or Space SSI) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 29: Global: Surgical Site Infection Control (Cesarean Section) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 30: Global: Surgical Site Infection Control (Cesarean Section) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 31: Global: Surgical Site Infection Control (Gastric Bypass) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 32: Global: Surgical Site Infection Control (Gastric Bypass) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 33: Global: Surgical Site Infection Control (Cataract Surgery) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 34: Global: Surgical Site Infection Control (Cataract Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 35: Global: Surgical Site Infection Control (Dental Restoration) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 36: Global: Surgical Site Infection Control (Dental Restoration) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 37: Global: Surgical Site Infection Control (Other Surgery Types) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 38: Global: Surgical Site Infection Control (Other Surgery Types) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 39: Global: Surgical Site Infection Control (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 40: Global: Surgical Site Infection Control (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 41: Global: Surgical Site Infection Control (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 42: Global: Surgical Site Infection Control (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 43: Global: Surgical Site Infection Control (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 44: Global: Surgical Site Infection Control (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 45: North America: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 46: North America: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 47: United States: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 48: United States: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 49: Canada: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 50: Canada: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 51: Asia-Pacific: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 52: Asia-Pacific: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 53: China: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 54: China: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 55: Japan: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 56: Japan: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 57: India: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 58: India: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 59: South Korea: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 60: South Korea: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 61: Australia: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 62: Australia: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 63: Indonesia: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 64: Indonesia: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 65: Others: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 66: Others: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 67: Europe: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 68: Europe: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 69: Germany: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 70: Germany: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 71: France: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 72: France: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 73: United Kingdom: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 74: United Kingdom: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 75: Italy: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 76: Italy: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 77: Spain: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 78: Spain: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 79: Russia: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 80: Russia: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 81: Others: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 82: Others: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 83: Latin America: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 84: Latin America: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 85: Brazil: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 86: Brazil: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 87: Mexico: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 88: Mexico: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 89: Others: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 90: Others: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 91: Middle East and Africa: Surgical Site Infection Control Market: Sales Value (in Million US$), 2018 & 2023
• Figure 92: Middle East and Africa: Surgical Site Infection Control Market: Breakup by Country (in %), 2023
• Figure 93: Middle East and Africa: Surgical Site Infection Control Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 94: Global: Surgical Site Infection Control Industry: SWOT Analysis
• Figure 95: Global: Surgical Site Infection Control Industry: Value Chain Analysis
• Figure 96: Global: Surgical Site Infection Control Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Surgical Site Infection Control Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Surgical Site Infection Control Market Forecast: Breakup by Product (in Million US$), 2024-2032
• Table 3: Global: Surgical Site Infection Control Market Forecast: Breakup by Infection Type (in Million US$), 2024-2032
• Table 4: Global: Surgical Site Infection Control Market Forecast: Breakup by Surgery Type (in Million US$), 2024-2032
• Table 5: Global: Surgical Site Infection Control Market Forecast: Breakup by End User (in Million US$), 2024-2032
• Table 6: Global: Surgical Site Infection Control Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 7: Global: Surgical Site Infection Control Market: Competitive Structure
• Table 8: Global: Surgical Site Infection Control Market: Key Players

The global surgical site infection control market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.78% during 2024-2032. The increasing surgical procedures, growing awareness about healthcare-associated infections, enhanced focus on patient safety, and surging healthcare expenditure are some of the major factors propelling the surgical site infection control market growth.

Surgical Site Infection Control Market Analysis:

Major Market Drivers: The rising cases of hospital-acquired infections and the increasing prevalence of chronic conditions, such as cancer, gastrointestinal disorders, cardiovascular diseases (CVDs), etc., due to the aging population, sedentary lifestyles, and unhealthy eating habits are propelling the adoption of surgical site infection control. Moreover, several favorable initiatives undertaken by the governing and non-governing agencies of various countries, such as the introduction of stringent guidelines and training programs focused on infection control practices, are propelling the surgical site infection control market.

Key Market Trends: The increasing prevalence of surgical site infections, ongoing technological advancements in infection control products, rising adoption of minimally invasive surgeries, and introduction of stringent regulatory standards are expected to propel the surgical site infection control market demand. Moreover, with the rise in healthcare expenditure globally, there is a growing focus on improving patient outcomes and reducing healthcare-associated infections, including SSIs. This trend is expected to drive the demand for advanced infection control solutions in surgical settings.

Competitive Landscape: Some of the leading surgical site infection control market companies are 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Merieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Molnlycke Health Care AB, Prescient Surgical, and Steris Corporation, among many others.

Geographical Trends: According to the report, North America currently dominates the overall market. The region represents one of the largest markets for surgical site infection control products and services globally. The market size is influenced by factors such as the increase in the number of surgical procedures, advanced healthcare infrastructures, wide presence of regulatory landscape, ongoing technological innovations, etc. The market has been experiencing steady growth due to the increasing awareness about healthcare-associated infections and the importance of infection prevention measures.

Challenges and Opportunities: Antibiotic resistance, compliance issues, cost consideration, and variations in surgical practices and protocols across different healthcare facilities are some of the challenges that the market is facing. However, advances in medical technology, such as the development of antimicrobial coatings, novel surgical materials, and robotic-assisted surgery, offer the surgical site infection control market recent opportunities to enhance infection control in surgical settings.

Surgical Site Infection Control Market Trends:

Rising Geriatric Population

Many regions worldwide are experiencing a demographic shift characterized by a growing proportion of older adults aged 65 and above. For instance, according to the World Health Organization, by 2030, one in every six persons in the world will be 60 or older. At this time, the proportion of the population aged 60 and up will rise from 1 billion in 2020 to 1.4 billion. By 2050, the global population of persons aged 60 and up will double (2.1 billion). The number of people aged 80 and older is anticipated to treble between 2020 and 2050, reaching 426 million. Older adults are more vulnerable to SSIs due to age-related changes in the immune system, reduced tissue healing capacity, and the presence of comorbidities such as diabetes, hypertension, and cardiovascular disease. As the geriatric population grows, there is a corresponding increase in the number of surgical procedures performed on older adults, leading to a higher demand for infection control measures to mitigate the risk of SSIs. For instance, according to an article published by the National Library of Medicine in March 2021, nearly 4 million surgical procedures were performed each year in older adults aged 65 years and above. In line with this, according to another article published by the National Library of Medicine in March 2023, in total knee replacement surgery, the SSI rates were higher in older adults aged 76-80 years when compared with the age group of 61-65 years. These factors are further bolstering the surgical site infection market revenue.

Increasing Surgical Procedure and Healthcare Infrastructure Development

There has been a significant increase in surgical procedures across the world. For instance, according to an article published by the National Library of Medicine, in September 2020, 11% of the world's illness burden necessitates surgical intervention, anesthetic management, or both. The most common procedures were for cataracts (22.8%), Caesareans (3.8%), fracture surgeries (3.27%), and hernias (2.86%). The necessary operations made up 44.2% of all surgeries. Moreover, healthcare infrastructure development initiatives, particularly in emerging markets, contribute to the growth of the surgical site infection control market. According to an article published by the India Investment Grid, public health expenditure is expected to rise to 2.5% of GDP by 2025. Apart from this, healthcare facilities and providers are increasingly investing in preventive strategies and technologies to minimize the incidence of SSIs. This includes the adoption of stringent protocols, advanced sterilization techniques, antimicrobial coatings for surgical instruments, and the utilization of high-tech materials in wound dressings and sutures. For instance, in December 2023, Flinders University and Chinese researchers collaborated to develop a new Ag-Ga orthopedic implant covering that is highly resistant to infection. The novel material could be readily and controllably put by spray-casting on numerous medical devices to protect them from infection while simultaneously providing an anti-inflammatory impact. Moreover, in October 2023, Sylke Inc. introduced SYLKE, the dressing manufactured from pure hypoallergenic silk fibroin. SYLKE promotes healing in surgical wounds and reduces complications and infections that might cause poor scarring. SYLKE seeks to transform surgical wound care by removing medical adhesive-related skin damage that causes infections and poor scarring outcomes.

Advances in Research Studies and Clinical Trials

Advances in research studies and clinical trials play a crucial role in driving growth in the surgical site infection control market by facilitating the development of innovative products, enhancing treatment strategies, and improving patient outcomes. For instance, in February 2024, PolyPid Ltd., a biopharmaceutical company dedicated to improving surgical outcomes, announced considerable progress in its SHIELD II Phase 3 clinical study, after enrolling its 100th patient. This research looked at the efficacy of D-PLEX100, a product candidate intended to prevent surgical site infections (SSIs) in abdominal colorectal procedures. Top-line results from the SHIELD II trial were expected in the second half of 2024, with about 40 locations actively participating in the study. Moreover, research studies and clinical trials contribute to the identification of best practices and guidelines for infection prevention and control in surgical settings. Evidence-based recommendations regarding preoperative preparation, surgical techniques, antimicrobial prophylaxis, and postoperative care help standardize protocols and improve adherence to infection control measures, ultimately reducing the incidence of SSIs and improving patient outcomes. For instance, in August 2023, Emory University performed research which included over 20,000 patients and used automated methods to provide feedback and evaluate performance, found a 12% increase in antibiotic prophylactic compliance and a 33% decrease in overall SSIs. Data presented at the Surgical Infection Society's 2023 annual meeting showed that a unique automated antibiotic prophylaxis approach significantly reduces surgical site infections. These factors are further positively influencing the surgical site infection control market forecast.

Surgical Site Infection Control Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global surgical site infection control market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, infection type, surgery type, and end user.

Breakup by Product:

Antibiotic Prophylaxis Products

Wound Care Dressings

Surgical Drapes

Surgical Clippers

Antiseptics and Disinfectants

Wound Irrigation Products

Others

Antibiotic prophylaxis products currently exhibit a clear dominance in the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes antibiotic prophylaxis products, wound care dressings, surgical drapes, surgical clippers, antiseptics and disinfectants, wound irrigation products, and others. According to the report, antibiotic prophylaxis products account for the majority of the global market share.

According to the surgical site infection control market outlook, antibiotic prophylaxis plays a crucial role in preventing surgical site infections (SSIs), which are a significant concern in healthcare settings. Antibiotics are usually administered shortly before surgical incision to achieve adequate tissue concentrations at the time of potential bacterial contamination. The timing of administration is critical and should ideally occur within 60 minutes before the surgical incision, although exceptions may exist for certain antibiotics and procedures. Moreover, prophylactic antibiotic regimens are often tailored to the specific requirements of different surgical procedures. For example, orthopedic surgeries may require coverage against Staphylococcus aureus and streptococci, while colorectal surgeries may necessitate additional coverage against gram-negative and anaerobic bacteria. For instance, in January 2024, the American Association for the Surgery of Trauma (AAST), the World Surgical Infection Society Europe (SIS-E), the Global Alliance for Infection in Surgery (GAIS), and the World Society of Emergency Surgery (WSES) collaborated to develop important guidelines for antibiotic prophylaxis (AP) in cases of traumatic lesions involving the head, brain, torso, maxillofacial region, extremities, skin, and soft tissues.

Breakup by Infection Type:

Superficial Incisional SSI

Deep Incisional SSI

Organ or Space SSI

Currently, superficial incisional SSI accounts for the majority of the global market share

A detailed breakup and analysis of the market based on the infection type have also been provided in the report. This includes superficial incisional SSI, deep incisional SSI, and organ or space SSI. According to the report, superficial incisional SSI currently holds the largest market share.

According to the surgical site infection market overview, superficial incisional surgical site infections (SSIs) represent a significant portion of all SSIs. These infections occur within 30 days after the operation and involve only the skin and subcutaneous tissue of the incision. They are often characterized by symptoms such as redness, warmth, swelling, and localized pain at the surgical site. They are among the most common types of SSIs encountered in surgical practice. Their relatively high incidence underscores their importance in infection control efforts. For instance, according to an article published by the National Library of Medicine in 2023, 59% of the total SSI patients had superficial SSI.

Breakup by Surgery Type:

Cesarean Section

Gastric Bypass

Cataract Surgery

Dental Restoration

Others

Cesarean section currently holds the largest market share

The report has provided a detailed breakup and analysis of the market based on the surgery type. This includes cesarean section, gastric bypass, cataract surgery, dental restoration, and others. According to the report, the cesarean section holds the largest share in the overall market.

Cesarean sections are one of the most common surgical procedures globally. In many countries, the rates of C-section deliveries have been increasing steadily over the years. With such a high volume of procedures, the prevention of SSIs in C-sections becomes a significant focus of infection control efforts. Moreover, the surgical site in a Cesarean section is particularly vulnerable to infection due to its proximity to the genital and gastrointestinal tracts, which harbor numerous bacteria. Additionally, the procedure involves breaching the protective barriers of the skin and uterine wall, increasing the risk of contamination. Apart from this, SSIs following Cesarean sections can have serious consequences for both the mother and the newborn. In addition to causing discomfort and prolonging hospital stays for the mother, SSIs can lead to complications such as endometritis, wound dehiscence, sepsis, and increased healthcare costs. There's also a risk of vertical transmission of pathogens to the newborn, which can result in neonatal infections. For instance, according to World Health Organization (WHO) data, the use of cesarean sections is increasing, accounting for more than one in every five (21%) childbirths in 2021. This figure is expected to rise further over the next decade, with almost one-third (29%) of all births by cesarean section by 2030.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Currently, hospitals exhibit a clear dominance in the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, ambulatory surgical centers, and others. According to the surgical site infection control market report, hospitals exhibit a clear dominance in the market.

The demand for surgical site infection (SSI) control in hospitals arises from various factors related to patient safety, healthcare quality, regulatory requirements, and financial considerations. Preventing SSIs is essential for ensuring patient safety and minimizing the risk of postoperative complications. SSIs can lead to significant morbidity, prolonged hospital stays, increased healthcare costs, and in severe cases, mortality. Hospitals have a moral and ethical obligation to provide safe and high-quality care to their patients, which includes implementing measures to control SSIs. Moreover, hospitals are increasingly focused on delivering high-quality care and maintaining a positive reputation within their communities. Preventing SSIs is a fundamental aspect of healthcare quality improvement efforts. Hospitals that effectively control SSIs are perceived as safer and more reliable by patients, healthcare professionals, insurers, and regulatory agencies.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America currently dominates the global market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.

According to the surgical site infection control market statistics, North America represents one of the largest markets for healthcare products and services globally. Within this context, the SSI control market encompasses a wide range of products, including antimicrobial agents, surgical drapes, gloves, sterilization equipment, wound care products, and surveillance systems. Despite advances in surgical techniques and infection control practices, SSIs remain a significant concern in North American healthcare facilities. The prevalence of SSIs varies across different surgical specialties and settings but represents a substantial clinical and economic burden on healthcare systems. For instance, in February 2021, Penn Medicine opened its new Interventional Support Center (ISC), making it one of the most prominent instrument processing and surgical supply preparation facilities in Southwest Philadelphia, United States. The ISC is one of Pennsylvania's first facilities of its sort, with staff sterilizing and packaging thousands of instruments daily in preparation for surgeries and procedures, ranging from basic scissors and clamps to complex robotic instruments. For instance, according to an article published by the National Library of Medicine, in February 2024, surgical site infections accounted for approximately two million nosocomial infections in the U.S., which considerably raises postoperative morbidity and mortality rates. In line with this, according to the international trial co-led by McMaster University and the University of Maryland School of Medicine in February 2024, thousands of patients yearly undergoing surgery for a closed fracture may avoid surgical site infections by using iodine povacrylex in alcohol to disinfect their skin.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players that are mentioned below:

3M Company

Ansell Limited

Becton Dickinson and Company

bioMerieux SA. (Institut Merieux)

Covalon Technologies Ltd.

GAMA Healthcare Ltd.

Getinge AB (Carl Bennet AB)

Johnson & Johnson

Kimberly-Clark Corporation

Molnlycke Health Care AB

Prescient Surgical

Steris Corporation

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Surgical Site Infection Control Market Recent Developments:

May 2024: Nanordica Medical, an Estonian medical technology firm, received €1.75 million to enter the market with first-in-class wound care solutions that treat serious wounds.

April 2024: Vomaris launched PowerHeal, a bioelectric bandage approved by the FDA for over-the-counter (OTC) use in the management of wounds.

February 2024: PolyPid Ltd., a biopharmaceutical company dedicated to improving surgical outcomes, announced considerable progress in its SHIELD II Phase 3 clinical study, after enrolling its 100th patient. This research looked at the efficacy of D-PLEX100, a product candidate intended to prevent surgical site infections (SSIs) in abdominal colorectal procedures.

Key Questions Answered in This Report

• 1. How big is the global surgical site infection control market?
• 2. What is the expected growth rate of the global surgical site infection control market during 2024-2032?
• 3. What are the key factors driving the global surgical site infection control market?
• 4. What has been the impact of COVID-19 on the global surgical site infection control market?
• 5. What is the breakup of the global surgical site infection control market based on the product?
• 6. What is the breakup of the global surgical site infection control market based on the infection type?
• 7. What is the breakup of the global surgical site infection control market based on the surgery type?
• 8. What is the breakup of the global surgical site infection control market based on the end user?
• 9. What are the key regions in the global surgical site infection control market?
• 10. Who are the key players/companies in the global surgical site infection control market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Surgical Site Infection Control Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Antibiotic Prophylaxis Products
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Wound Care Dressings
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Surgical Drapes
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Surgical Clippers
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Antiseptics and Disinfectants
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Wound Irrigation Products
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Others
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast

7 Market Breakup by Infection Type

• 7.1 Superficial Incisional SSI
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Deep Incisional SSI
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Organ or Space SSI
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Surgery Type

• 8.1 Cesarean Section
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Gastric Bypass
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Cataract Surgery
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Dental Restoration
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Surgical Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 3M Company
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Ansell Limited
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Becton Dickinson and Company
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 bioMerieux SA. (Institut Merieux)
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Covalon Technologies Ltd.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 GAMA Healthcare Ltd.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Getinge AB (Carl Bennet AB)
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Johnson & Johnson
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Kimberly-Clark Corporation
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Molnlycke Health Care AB
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 SWOT Analysis
  • 15.3.11 Prescient Surgical
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 Steris Corporation
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio